Suppr超能文献

子宫内膜癌:妇科肿瘤学学会基于证据的综述和推荐。

Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations.

机构信息

Gynecologic Oncology Section, Women's Services and The Ochsner Cancer Institute, Ochsner Health, New Orleans, LA, United States of America.

Department of Obstetrics and Gynecology, NYU School of Medicine, New York City, NY, United States of America.

出版信息

Gynecol Oncol. 2021 Mar;160(3):817-826. doi: 10.1016/j.ygyno.2020.12.021. Epub 2021 Jan 27.

Abstract

INTRODUCTION

In 2014, the Society of Gynecologic Oncology's Clinical Practice Committee published a clinical update reviewing the treatment of women with endometrial cancer. At that time, there had been significant advances in the diagnosis, work-up, surgical management, and available treatment options allowing for more optimal care of affected women. Despite these advances, the incidence of endometrial cancer as well as the deaths attributable to the disease have continued to rise; from 1987 to 2014 there has been a 75% increase in cases and almost 300% increase in endometrial cancer deaths. Fortunately, since then, there has been progress in the treatment of patients with endometrial cancer with increased utilization of molecular pathology, greater understanding of genetic predisposition, enhanced methods for lymph node assessment, a broader understanding of the efficacy of radiation and chemotherapy, and a more efficient approach to survivorship and surveillance. The purpose of this document is to present a comprehensive review of this progress.

MANUSCRIPT DEVELOPMENT PROCESS

The authors reviewed the available evidence, contributed to the development of this manuscript, provided critical review of the guidelines, and finalized the manuscript recommendations. The review was also presented to and approved by the Society of Gynecologic Oncology (SGO) Clinical Practice Committee, SGO Publications Committee, and the SGO board members prior to submission for publication. The recommendations for this manuscript were developed by a panel of gynecologic oncologists who were members of the SGO Clinical Practice and Education Committees. Panelists reviewed and considered evidence from current uterine cancer literature. The terminology used in these guidelines was adopted from the ASCCP management guidelines [1] using a two-part rating system to grade the strength of recommendation and quality of evidence (Table 1). The rating for each recommendation is given in parentheses.

摘要

简介

2014 年,妇科肿瘤学协会临床实践委员会发布了一份临床更新,回顾了子宫内膜癌患者的治疗。当时,在诊断、检查、手术管理和现有治疗方案方面都取得了重大进展,从而能够为受影响的女性提供更优的治疗。尽管取得了这些进展,但子宫内膜癌的发病率以及归因于该疾病的死亡率仍在持续上升;自 1987 年至 2014 年,病例数增加了 75%,而子宫内膜癌的死亡人数增加了近 300%。幸运的是,自那时以来,子宫内膜癌患者的治疗取得了进展,分子病理学的应用更加广泛,对遗传易感性的认识不断加深,淋巴结评估方法得到了增强,对放化疗疗效的理解更加全面,以及对生存和监测的处理方法更加高效。本文的目的是对这些进展进行全面综述。

文稿开发流程

作者回顾了现有证据,为本文稿的撰写做出了贡献,对指南进行了批判性审查,并最终确定了文稿建议。该综述还提交给了妇科肿瘤学协会(SGO)临床实践委员会、SGO 出版委员会以及 SGO 董事会成员进行了审议和批准,然后才提交出版。本文稿的建议由妇科肿瘤学家组成的小组制定,他们是 SGO 临床实践和教育委员会的成员。小组成员审查并考虑了当前子宫癌文献中的证据。这些指南中使用的术语来自 ASCCP 管理指南[1],采用两级评分系统对推荐的强度和证据的质量进行分级(表 1)。每个建议的评级都在括号内给出。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验